Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life
Submitted: 3 December 2019
Accepted: 15 April 2020
Published: 23 July 2020
Accepted: 15 April 2020
Abstract Views: 1347
PDF: 984
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- A. Laria, A. Zoli, E. Gremese, G.F. Ferraccioli, Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections , Reumatismo: Vol. 63 No. 1 (2011)
- M. Rossini, F. Bertoldo, R. Lovato, R. Bortolotti, D. Gatti, S. Adami, Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures , Reumatismo: Vol. 54 No. 4 (2002)
- S. Bello, C. Bonali, L. Serafino, C. Rotondo, N. Terlizzi, G. Lapadula, Intra-articular therapy with tumor necrosis factor-α antagonists: an update , Reumatismo: Vol. 65 No. 6 (2013)
- G. Adami, S. Zanon, A. Fassio, G. Pesarini, M. Pighi, R. Scarsini, D. Tavella, M. Rossini, D. Gatti, F. Ribichini, Diffuse idiopathic skeletal hyperostosis is associated with greater complexity of coronary artery disease burden on coronary angiography , Reumatismo: Early Access
- L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio, Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project , Reumatismo: Vol. 61 No. 1 (2009)
- M. Manara, D. Bruno, M. Ferrito, S. Perniola, R.F. Caporali, E. Gremese, Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology , Reumatismo: Vol. 76 No. 3 (2024)
- F. Salaffi, A. Stancati, M. Carotti, R. Lorenzetti, W. Grassi, The impact of vertebral fractures on quality of life in postmenopausal women with osteoporosis. Validity of the Italian version of mini-Osteoporosis Quality of Life Questionnaire , Reumatismo: Vol. 57 No. 2 (2005)
- I. Bertoldi, B. Frediani, Osteoarthritis and osteoporosis: correlations between two clinical entities , Reumatismo: Vol. 65 No. 2 (2013)
- A. Trotta, A. Corrado, F.P. Cantatore, Anabolic therapy in b-thalassaemia major induced osteoporosis: case report and literature review , Reumatismo: Vol. 62 No. 2 (2010)
- O. Viapiana, D. Gatti, M. Rossini, L. Idolazzi, E. Fracassi, S. Adami, Vitamin D and fractures: a sistematic review , Reumatismo: Vol. 59 No. 1 (2007)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.